Gynostemma Extract (Gynostemma pentaphyllum extract)

Gynostemma extract contains gypenosides, saponin compounds that demonstrate antioxidant and anti-inflammatory activity through inhibition of pro-inflammatory cytokines. The extract shows preliminary evidence for radical scavenging activity and potential antiproliferative effects in laboratory studies.

Origin & History

Gynostemma extract is derived from the leaves and stems of Gynostemma pentaphyllum, a perennial climbing vine native to mountainous regions of China, Japan, and Korea, commonly known as jiaogulan. The extract is typically produced using solvents such as 50% acetone, 75% or 95-100% ethanol, or methanol, followed by fractionation and purification via macroporous resin columns or HPLC.

Historical & Cultural Context

The research dossier provides no information on traditional use, historical context, or traditional medicine applications. No data on duration of traditional use or specific cultural practices were included in the available research.

Health Benefits

• Antioxidant activity through DPPH and hydroxyl radical scavenging (preliminary in vitro evidence only)
• Anti-inflammatory effects via dose-dependent inhibition of IL-6 and COX-2 mRNA expression (preliminary in vitro evidence only)
• Potential antiproliferative effects in HT-29 colon cancer cells at 3.2 mg equiv/mL (preliminary in vitro evidence only)
• Weak TNF-α inhibition suggesting immune modulation (preliminary in vitro evidence only)
• No human clinical evidence available for any health benefits

How It Works

Gynostemma extract's primary bioactive compounds, gypenosides, exhibit antioxidant activity through DPPH and hydroxyl radical scavenging mechanisms. These saponins demonstrate anti-inflammatory effects by dose-dependently inhibiting IL-6 and COX-2 mRNA expression. The extract also shows antiproliferative activity in cancer cell lines, though the specific molecular pathways remain under investigation.

Scientific Research

No human clinical trials, RCTs, or meta-analyses for Gynostemma pentaphyllum extract were found in the research dossier. Available evidence is limited to in vitro studies showing antioxidant, anti-inflammatory, and antiproliferative effects, with no PubMed PMIDs for human studies provided.

Clinical Summary

Current evidence for gynostemma extract is limited to preliminary in vitro studies examining antioxidant and anti-inflammatory mechanisms. Laboratory research has demonstrated dose-dependent inhibition of inflammatory markers IL-6 and COX-2, along with radical scavenging activity against DPPH and hydroxyl radicals. Antiproliferative effects have been observed in HT-29 colon cancer cell lines. No human clinical trials have been conducted to establish therapeutic efficacy or optimal dosing protocols.

Nutritional Profile

Gynostemma pentaphyllum extract is a concentrated botanical preparation with negligible macronutrient content (carbohydrates, proteins, and fats present only in trace amounts at typical extract doses of 100–450 mg). Primary bioactive compounds are triterpenoid saponins called gypenosides (gynosaponins), with total gypenoside content typically standardized to 20–98% in commercial extracts; over 100 individual gypenosides have been identified, with gypenoside XLIX, gypenoside XVII, and damulin A and B among the most pharmacologically studied. Structurally, approximately 80% of gypenosides share backbone similarities with Panax ginseng ginsenosides (particularly Rb1, Rd, and Rg3 analogs), contributing to its adaptogenic classification. Polysaccharides (gypenans) are present at approximately 3–8% in whole-leaf preparations and contribute to immunomodulatory activity, though concentrations vary significantly by extraction method. Flavonoids including rutin, quercetin, and ombuoside are present at roughly 0.5–2% of dry extract weight. Chlorophyll derivatives and carotenoids are present in non-purified extracts. Minor minerals detectable in whole-leaf preparations include potassium (~1,200 mg/100g dry leaf), calcium (~200 mg/100g dry leaf), magnesium (~60 mg/100g dry leaf), and iron (~15 mg/100g dry leaf), though these are substantially diluted or removed in concentrated extracts. Bioavailability of gypenosides is limited by poor intestinal absorption of intact saponins; gut microbiota hydrolysis to aglycone forms (dammarane-type) is considered the primary absorption pathway, meaning bioavailability is microbiome-dependent and highly variable between individuals. Water-based and ethanol-based extracts (40–70% ethanol) yield differing gypenoside profiles, with aqueous extracts favoring polar gypenosides and polysaccharides, and ethanolic extracts concentrating more lipophilic aglycone-rich fractions.

Preparation & Dosage

No clinically studied dosage ranges are available as human trials are absent. Extraction yields show gypenosides at 7.43 mg/g in tetraploid leaves using 95% ethanol reflux, but no standardization or therapeutic dosing has been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea extract, Rhodiola, Ashwagandha, Schisandra, Eleuthero

Safety & Interactions

Safety data for gynostemma extract is limited due to lack of human clinical trials. No significant adverse effects have been reported in available preliminary studies. Potential interactions with anticoagulant medications may occur due to saponin content, though this has not been clinically documented. Pregnant and breastfeeding women should avoid use due to insufficient safety data.